Literature DB >> 32221825

Feasibility of an interprofessional collaborative osteoporosis screening programme in Malaysia.

Li Shean Toh1, Pauline Siew Mei Lai2, Bee Yean Low3, Kok Thong Wong3, Claire Anderson4.   

Abstract

Background Population screening for osteoporosis using bone mineral density scan is not feasible in Malaysia as this test is costly. Hence, there is a need to develop a more efficient method to screen for osteoporosis.Objectives To determine the feasibility of an interprofessional collaborative osteoporosis screening programme (IPC-OSP). Methods Postmenopausal women aged ≥ 50 years, who had not been diagnosed with osteoporosis were recruited from a primary care clinic from June to August 2014. Patients were assessed for their osteoporosis risk and were counselled on prevention methods. Patients at risk were referred to the doctor with a recommendation for a bone mineral density (BMD) scan. Results Fifty out of 55 patients were recruited (response rate = 90.9%). A total 26/50 (52.0%) went for a bone mineral density scan, none were osteoporotic, 17/50 (34%) were osteopenic, 2/50 (4.0%), were started on osteoporosis medications and 14/50 (28%) modified their lifestyle to improve bone health or started on calcium supplements. Osteoporosis knowledge significantly increased from baseline to month two (46.3 ± 21.4 vs. 79.1 ± 14.3, p < 0.001). Patients had a satisfaction score of 89.8 ± 12.4. Follow-up rates were 83.9% and 100% at months 1 (BMD appointment) and 2 (phone follow up), respectively. The intervention was successfully coordinated. Data entry was determined to be viable based on the researchers' experience. Conclusion The interprofessional collaborative osteoporosis screening programme was found to be feasible in Malaysia.

Entities:  

Keywords:  Feasibility; Interprofessional care; Intervention; Malaysia; Osteoporosis; Pharmacists; Screening

Year:  2020        PMID: 32221825     DOI: 10.1007/s11096-019-00960-x

Source DB:  PubMed          Journal:  Int J Clin Pharm


  9 in total

1.  Nuts and bolts of conducting feasibility studies.

Authors:  Linda Tickle-Degnen
Journal:  Am J Occup Ther       Date:  2013 Mar-Apr

2.  Impact of a pharmacist-directed intervention in postmenopausal women after fracture.

Authors:  Rachel M F Heilmann; Cari R Friesleben; Sarah J Billups
Journal:  Am J Health Syst Pharm       Date:  2012-03-15       Impact factor: 2.637

3.  A simple tool to identify asian women at increased risk of osteoporosis.

Authors:  L K Koh; W B Sedrine; T P Torralba; A Kung; S Fujiwara; S P Chan; Q R Huang; R Rajatanavin; K S Tsai; H M Park; J Y Reginster
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

4.  Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial.

Authors:  N Yuksel; S R Majumdar; C Biggs; R T Tsuyuki
Journal:  Osteoporos Int       Date:  2009-06-05       Impact factor: 4.507

Review 5.  The impact of pharmacist interventions on osteoporosis management: a systematic review.

Authors:  M N Elias; A M Burden; S M Cadarette
Journal:  Osteoporos Int       Date:  2011-07-01       Impact factor: 4.507

6.  The Development and Validation of the Osteoporosis Prevention and Awareness Tool (OPAAT) in Malaysia.

Authors:  Li Shean Toh; Pauline Siew Mei Lai; David Bin-Chia Wu; Kok Thong Wong; Bee Yean Low; Claire Anderson
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

7.  Clinician's Guide to Prevention and Treatment of Osteoporosis.

Authors:  F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal:  Osteoporos Int       Date:  2014-08-15       Impact factor: 4.507

8.  The development and validation of the Satisfaction Questionnaire for Osteoporosis Prevention in Malaysia.

Authors:  Li Shean Toh; Pauline Siew Mei Lai; David Bin-Chia Wu; Kok Thong Wong; Bee Yean Low; Alexander Tong Boon Tan; Claire Anderson
Journal:  Patient Prefer Adherence       Date:  2014-09-30       Impact factor: 2.711

9.  A tutorial on pilot studies: the what, why and how.

Authors:  Lehana Thabane; Jinhui Ma; Rong Chu; Ji Cheng; Afisi Ismaila; Lorena P Rios; Reid Robson; Marroon Thabane; Lora Giangregorio; Charles H Goldsmith
Journal:  BMC Med Res Methodol       Date:  2010-01-06       Impact factor: 4.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.